Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Post by labumbaon Jul 21, 2008 3:14pm
239 Views
Post# 15313739

Roche will opt in !

Roche will opt in !almost two months gone....if they wanted out, you should have known it by now.....why wastes their time and yours...of course, they have lots of other things to consider like a  comprehensive package on the top of the " opt-in "......involves Psoraisis indication....ISA board control is another matter....

keep it in mind....there are ONLY two " front line" immunosuppressive drugs in today market and these drugs have been on the market since 1964 (? )......Voclosporin is already half way through the drug development process and so far so good !....there are other indications in the pipeline for Voclosporin...one will be in the NDA process next year.....think about it and be rational if you were in their shoes
Bullboard Posts